Cragmont Pharmaceuticals, LLC
Records under this name other than patents Cragmont Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Cragmont Pharmaceuticals, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,933,301 | 1,2,3,6-tetrahydropyrimidine-2-one compositions, articles and therapeutic methods for upper airway breathing disorders Lapsed on the fee record Ended Aug 23, 2017 · USPTO record | Lapsed on the fee record | Ended Aug 23, 2017 | USPTO record |
| US 6,919,348 | Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith Lapsed on the fee record Ended Jul 19, 2017 · USPTO record | Lapsed on the fee record | Ended Jul 19, 2017 | USPTO record |
| US 6,743,801 | 1,2,3,6-tetrahydropyrimidine-2-one compositions and therapeutic methods therewith for pain and inflammation Lapsed on the fee record Ended Jun 1, 2016 · USPTO record | Lapsed on the fee record | Ended Jun 1, 2016 | USPTO record |
| US 5,744,452 | .gamma.-L-glutamyl containing immunomodulator compounds and methods therewith Term ended Term ended no later than Apr 28, 2018 · Low confidence | Term ended | Term ended no later than Apr 28, 2018 | Low confidence |
| US 5,916,878 | .Gamma.-glutamyl and .beta.-aspartyl containing immunomodulator compounds and methods therewith Term ended Term ended no later than Jun 29, 2019 · Low confidence | Term ended | Term ended no later than Jun 29, 2019 | Low confidence |